Salix Pharmaceuticals Ltd.’s(SLXP) MACD indicator has moved into bearish territory with a reading of -0.1085. The Zacks #4 Rank (“Sell) stock fell more than 4% to $18.31 in afternoon trade. The Zacks Consensus Estimate on the company’s full-year earnings is currently pegged at a loss of 92 cents per share, which has worsened by 2 cents over the past 2 months.
“SLXP” Free Stock Analysis: Buy? Sell? Hold?
Zacks Investment Research